Outpatient infusion care is changing. Payer policies increasingly impact where patients can receive provider-administered medications and how providers are reimbursed for these medications. This library contains our top resources for pharmacy leaders working to protect health system infusion services and support contract negotiations.
Pharmacogenomics (PGx) is the science of understanding the influence of a person’s genome on drug treatment outcomes. Provider-based PGx programs are not currently widespread—they mostly exist in large academic medical centers and in some community hospitals with strong use cases (e.g., those with large oncology or mental health patient populations).
Confronting a new challenge? Ask our experts for help.
You have urgent, complex questions that need fast, clear solutions. AskAdvisory is our new service designed to get you the answers you’re looking for right now.
